Q2 2025 Becton Dickinson and Co Earnings Call Transcript
Key Points
- Becton Dickinson & Co (BDX) exceeded adjusted EPS growth expectations, delivering strong performance down the P&L.
- The company achieved adjusted gross margins of 54.9%, increasing year-over-year by 190 basis points.
- BD Excellence continues to drive gross margin expansion, with four consecutive quarters of strong performance.
- The company announced its intent to invest $2.5 billion in US manufacturing over the next five years, strengthening its position.
- BDX is making meaningful pipeline advances, including the launch of new products like Phasix ST Umbilical and BD Nexus.
- Revenues came in below expectations, growing only 0.9% organically, due to market dynamics in life sciences and diagnostics.
- The company adjusted its full-year revenue guidance, now expecting 3% to 3.5% organic growth, down from previous expectations.
- Bioscience performance was impacted by a reduction in global research funding, affecting research instrument sales.
- The diagnostics segment faced challenges with slower-than-expected recovery in blood culture testing levels.
- Tariff expenses are expected to impact the company, with an estimated $90 million expense in FY25, predominantly in Q4.
Hello, and welcome to BD's second fiscal quarter 2025 earnings call. At the request of BD, today's call is being recorded and will be available for replay on BD's Investor Relations website, investors.bd.com, or by phone at (800) 839 2385 for domestic calls and area code plus +1 (402) 220-7203 for international calls. (Operator Instructions)
I will turn the call over to Greg Rodetis, Senior Vice President, Treasurer and Head of Investor Relations.
Good morning, and welcome to BD's earnings call. I'm Greg Rodetis, Senior Vice President, Treasurer and Head of Investor Relations. Thank you for joining us. This call is being made available via audio webcast at bd.com. Earlier this morning, BD released its results for the second quarter of fiscal 2025. The press release and presentation can be accessed on the IR website at investors.bd.com.
Leading today's call are Tom Polen, BD's Chairman, Chief Executive Officer and President; and Chris
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
